<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01086800</url>
  </required_header>
  <id_info>
    <org_study_id>1RC2HL101417-01</org_study_id>
    <nct_id>NCT01086800</nct_id>
  </id_info>
  <brief_title>Heart Biomarker Evaluation in Apnea Treatment</brief_title>
  <acronym>HeartBEAT</acronym>
  <official_title>Phase II Trial of Sleep Apnea Treatment to Reduce Cardiovascular Morbidity</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Brigham and Women's Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Case Western Reserve University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Partners HealthCare</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Johns Hopkins University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>VA Boston Healthcare System</agency>
      <agency_class>U.S. Fed</agency_class>
    </collaborator>
  </sponsors>
  <source>Brigham and Women's Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study examines the role of sleep apnea treatment in improving cardiovascular biomarkers.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a Phase II randomized controlled trial that will evaluate the effects of supplemental
      nocturnal oxygen or Positive Airway Pressure (PAP) therapy, compared to optimal medical
      preventive therapy for Cardiovascular Disease (CVD) risk, on biomarkers of CVD risk in
      Obstructive Sleep Apnea (OSA) patients at high risk for CVD events. The study will focus on
      patients with moderate to severe OSA but only mild OSA symptoms.

      Eligible participants have a history or symptoms of heart disease AND have symptoms of sleep
      apnea or snoring. Participants will be contributing to medical knowledge about different
      options that can be used to improve heart disease in people with sleep apnea.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2010</start_date>
  <completion_date type="Actual">August 2012</completion_date>
  <primary_completion_date type="Actual">January 2012</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>To compare the effects of nocturnal supplemental oxygen and PAP versus optimized medical management on biomarkers of cardiovascular risk, including:</measure>
    <time_frame>3 months</time_frame>
    <description>24 hour blood pressure (BP) profile
Markers of systemic inflammation
Markers of oxidative stress
Prothrombotic markers
Sympathetic nervous system activity
Cardiac rhythm, impulse generation and ischemia
Dyslipidemia
Glucose regulation
Myocardial stress</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Compare the effects of nocturnal supplemental oxygen and PAP versus standard care on patient-reported outcomes, including:</measure>
    <time_frame>3 months</time_frame>
    <description>vitality
self reported sleepiness</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Compare nocturnal supplemental oxygen and PAP on measures of:</measure>
    <time_frame>3 months</time_frame>
    <description>efficacy (AHI, hypoxemia)
adherence
side effects</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">318</enrollment>
  <condition>Cardiovascular Disease</condition>
  <condition>Obstructive Sleep Apnea</condition>
  <condition>Coronary Artery Disease</condition>
  <arm_group>
    <arm_group_label>HLSE plus PAP</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>HLSE plus Oxygen</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy Lifestyles and Sleep Education</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Healthy Lifestyles and Sleep Education plus PAP</intervention_name>
    <description>Participants randomized to this arm will be educated on PAP and then use PAP for 3 months. They will also receive optimized medical preventive therapy according to current American Heart Association guidelines for prevention of CVD and sleep guidelines.</description>
    <arm_group_label>HLSE plus PAP</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Healthy Lifestyles and Sleep Education plus Supplemental Oxygen</intervention_name>
    <description>Participants randomized to this arm will be educated on nocturnal supplemental oxygen and then use oxygen for 3 months. They also will receive optimized medical preventive therapy according to current American Heart Association guidelines for prevention of CVD and sleep guidelines.</description>
    <arm_group_label>HLSE plus Oxygen</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Healthy Lifestyles and Sleep Education</intervention_name>
    <description>Participants randomized to this arm will receive optimized medical preventive therapy according to current American Heart Association guidelines for prevention of CVD and sleep guidelines.</description>
    <arm_group_label>Healthy Lifestyles and Sleep Education</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  established Coronary Artery Disease or established cardiovascular disease risk factors

          -  home sleep test that showed moderately severe sleep apnea

        Exclusion Criteria:

          -  poorly controlled health

          -  currently using supplemental oxygen or PAP for OSA
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>45 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Susan Redline, MD, MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>Brigham and Women's Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Johns Hopkins University</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21224</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Partners HealthCare</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02115</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>VA Boston Healthcare System</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02132</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Case Western Reserve University</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44106</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 12, 2010</study_first_submitted>
  <study_first_submitted_qc>March 12, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 15, 2010</study_first_posted>
  <last_update_submitted>February 21, 2013</last_update_submitted>
  <last_update_submitted_qc>February 21, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 25, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Brigham and Women's Hospital</investigator_affiliation>
    <investigator_full_name>Susan Redline</investigator_full_name>
    <investigator_title>Senior Physician, Division of Sleep Medicine</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Apnea</mesh_term>
    <mesh_term>Cardiovascular Diseases</mesh_term>
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
    <mesh_term>Sleep Apnea, Obstructive</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

